1. Market Research
  2. > Healthcare
  3. > Medical Device
  4. > In Vitro Diagnostics Market Trends
  5. > In Vitro Diagnostics (IVD) Market Outlook in China

In Vitro Diagnostics (IVD) Market Outlook in China

  • August 2013
  • -
  • Frost & Sullivan
  • -
  • 81 pages

Rising local participants will reshape this market

The IVD market in China presents diversified growth potential for different tiers of participants: domestic participants stand to gain from the growth momentum in the lower-end market, whereas foreign leading manufacturers dominate the high-end market. This research service analyzes the IVD market and provides forecasts and opportunities by understanding the market dynamics and trends. The market can be divided into segments such as clinical chemistry, immunoassay, molecular biology diagnostics, microbiology, coagulation, and hematology. The study covers the period 2007-2016.

Executive Summary

•The Chinese in-vitro diagnostics (IVD) market of $X billion in 2011 is expected to grow at a compound annual growth rate (CAGR) of X percent to reach $X billion in 2016.
•Based on testing principles, the IVD market is segmented into eight, and dominated by four of them, namely, immunoassay, clinical chemistry, hematology, and molecular diagnostics. The four constituted Xpercent of the total market in 2011, standing at $X million.
•Market growth for the traditional segments—Immunoassays, clinical chemistry, hematology, coagulation, and microbiology—are related to the increasing test volume, rather than the higher testing price. The emerging segment is molecular diagnostics, which is experiencing strong growth rates due to its innovation technology. POCT (Point-of-Care-Testing) is at a nascent stage. Although some companies have entered these two segments, they still need time to promote the POCT products and regularize the segment itself. Unlike SMBG (Self-Monitoring of Blood-Glucose), POCT is expected to have stronger growth potential because of policy support.
•The government provides a favorable policy environment for the IVD industry in the form of keeping investment in the primary healthcare system, providing public hospital reforms, encouraging IVD-related technology innovation for local participants, and improving reimbursement policy.
•The IVD market in China presents diversified growth potential for different tiers of competitors: domestic participants gain from the growth momentum for the low-end market, whereas foreign leading manufacturers dominate the high-end market, which is expected to become the new emerging market along with ever-improving localized service to meet various demands.
•Foreign companies dominate the high-end market by leveraging their technical advantage to develop closed-end systems for their automatic analyzers. The mid-to-low-end market is crowded with local participants, thus leading to fierce competition.
•Leading local companies have successfully built their brand reputation and are strengthening their research and development (R&D) capabilities to enter the high-end market by developing substitution devices at a lower cost to replace imported devices in some of the price-sensitive, lower-end hospitals. Some of them are trying to replicate the business models of multinational corporations to develop closed-end automatic analyzers of their own.
•Overall, the substitution devices developed by local companies are the most important factor in increasing the IVD market size, as it improves the accessibility of lower-level hospitals to advanced IVD technologies, thus boosting their need to update IVD products.

Past, Present, and Future IVD Market in China

Past 2000:
•Market size: $X million.
•Major market segments: Clinical chemistry, immunoassay, and hematology.
•Local manufacturers focus areas: Clinical chemistry, urine strips, and microplate enzyme immunoassay.
•Market domination: Multinational IVD companies.

Present 2011:
•Market size: $X million.
•Major market segments: Immunoassay, clinical chemistry, and SMBG.
•Local manufacturers focus areas: Immunoassay, clinical chemistry, and molecular testing, especially polymerase chain reaction (PCR) testing.

Future 2020:
•Market size: $Xmillion*.
•Major market segments: Immunoassay, SMBG, clinical chemistry, and molecular testing.
•Local manufacturers focus areas: Molecular testing, POCT, SMBG, immunoassay.
•Market domination: Multinational IVD companies and local companies share the market in most segments, despite the likelihood of foreign companies dominating the hematology, coagulation and microbiology segments.

Opportunities in Emerging Segments

Molecular Diagnostics
Product
•Hepatitis, HIV, and HPV tests are expected to be the key growth drivers.
•Respiratory disease and sexually-transmitted disease testing generate the most revenue in the market.
•Opportunities are emerging in areas such as cancer testing and PCR blood bank.
Technology
•Chip-based tests and multiplexing tests are the topic of discussion in research.
•Fast molecular testing in microbiology is gaining focus.
End User
•The adoption level is low in hospitals of all sizes because of the high cost and low or no reimbursement.
•Low-throughput automated analyzers with minimal human interference can help penetrate the market better.

POCT
Product
•Infectious disease testing is likely to become popular in the forecast period.
•Cardiac testing products are likely to become popular, as cardiac patient monitoring is very important in preventing a sudden onset of cardiac failure.
•Production standardization is needed.
Technology
•Immunochromotography-based tests are likely to dominate the market in the forecast period.
•Technology focused on enhancing the accuracy, sensitivity, and reliability of POCT testing could be the next trend.
End User
•Providing convenient monitoring and testing services in clinical centers in remote, rural areas would require robust POCT products.
•Rising disease prevention awareness among the Chinese is expected to boost demand for POCT products.

Table Of Contents

In Vitro Diagnostics (IVD) Market Outlook in China
Table of Contents

1. Executive Summary
2. Market Overview—Segmentation
• Market Life Cycle
• Healthcare Structure and Financing
• Medical Insurance System
• Processes of IVD Products
• In Vitro Diagnostics Overview
3. Market Drivers and Restraints
• Market Drivers
• Market Restraints
4. Total IVD Market Forecast
5. Competitive Analysis
6. Molecular Diagnostics Segment
7. Clinical Chemistry Segment
8. Immunoassay Segment
9. Microbiology Segment
10. POCT Segment
11. Coagulation Segment
12. SMBG Segment
13. Hematology Segment
14. Conclusions and Recommendations
15. Legal Disclaimer
16. The Frost and Sullivan Story

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
2016 POC/Point-of-Care Testing Markets: Cancer Clinics, Ambulatory Centers, Surgery Centers, Nursing Homes, Birth Centers-- Volume and Sales Segment Forecasts, Emerging Technologies, Instrumentation Review, Competitive Strategies

2016 POC/Point-of-Care Testing Markets: Cancer Clinics, Ambulatory Centers, Surgery Centers, Nursing Homes, Birth Centers-- Volume and Sales Segment Forecasts, Emerging Technologies, Instrumentation Review, Competitive Strategies

  • $ 7500
  • Industry report
  • October 2016
  • by Venture Planning Group

This 1,007-page report provides a comprehensive analysis of the emerging POC market segments, including their dynamics, size, growth, regulatory requirements, technological trends, competitive landscape, ...

Point of Care Diagnostics, BCC Research

Point of Care Diagnostics, BCC Research

  • $ 6650
  • Industry report
  • November 2016
  • by BCC Research

Use this report to: - Review business opportunities in the thriving near-patient testing market. - Learn about the impact of chronic diseases, growing and aging populations. - Receive information about ...

2016 World In Vitro Diagnostic Instrumentation Review

2016 World In Vitro Diagnostic Instrumentation Review

  • $ 6500
  • Industry report
  • October 2016
  • by Venture Planning Group

This new report from VPGMarketResearch.com reviews operating characteristics and features of major automated and semi-automated high-, medium-, and low-volume/POC in vitro diagnostic systems within the ...


ref:plp2013

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.